Communications
J . Org. Chem., Vol. 63, No. 18, 1998 6079
Sch em e 2a
Sch em e 3a
a
a
Key: (a) TsCl, DMAP, CH2Cl2; (b) BnNH2 (to give 6a ); KSAc, DMF
(to give 6b); (c) (i) 20% Pd(OH)2/C, H2, ethanol, (ii) 10% Pd/C,
ammonium formate, methanol (alternatively 10% Pd/C, ammonium
formate, methanol, one step) (to give 7).
Key: (a) 20% Pd(OH)2/C, H2, ethanol; (b) TIPDSCl2, anhydrous
pyridine; (c) KSAc, DMF; (d) TBAF, THF. [Si] ) 1,1,3,3-tetraisoprop-
yldisiloxane-1,3-diyl.
that 7 (2′-amino-LNA nucleoside, Figure 2, Y ) NH) and 11
(2′-thio-LNA nucleoside, Figure 2, Y ) S), like the parent
LNA nucleosides (Figure 2, Y ) O), exist in 3′-endo type
conformations. This conclusion is substantiated by the
strong and unusual NOEs observed between H-3′ and H-6
for compounds 6b and 7.10
Debenzylation of 2′-thio nucleoside 6b proved impossible in
our hands. Thus, probably because of catalyst poisoning,
catalytical hydrogenations (20% Pd(OH)2/C, H2, ethanol; 10%
Pd/C, H2, methanol; 10% Pd/C, 1,4-cyclohexadiene, metha-
nol) failed. Likewise, when a variety of other methods (BCl3,
dichloromethane, hexane; 20% Pd(OH)2/C, ammonium for-
mate, methanol; BBr3, dichloromethane; sodium, ethanol;
CrO3/CH3COOH; iodotrimethylsilane) were employed,7 ei-
ther no reaction or cleavage of the glycosidic bond was
observed (Scheme 2).
To obtain the desired 2′-thio nucleoside 11, the synthetic
strategy depicted in Scheme 3 was followed. Debenzylation
(49% yield, 20% Pd(OH)2/C, H2) of the di-O-tosylated uracil
nucleoside 5b to give 8 followed by 3′,5′-di-O-silylation in
97% yield using the bidentate reagent 1,3-dichloro-1,1,3,3-
tetraisopropyldisiloxane (TIPDSCl2) afforded the bicyclic
intermediate 9. Conversion of 9 into the tricyclic intermedi-
ate 10 was accomplished in 77% yield by reaction with
potassium thioacetate in DMF. Eventually, desilylation
using tetrabutylammonium fluoride (TBAF) in THF afforded
the desired 2′-thio-LNA nucleoside 11 [1-(2-deoxy-2-mer-
capto-2-S,4-C-methylene-â-D-ribofuranosyl)uracil] in 69%
yield.
On the basis of the results reported herein and earlier,3,5
the bicyclo[2.2.1] nucleoside skeleton appears very attractive
as a structural element of nucleic acid mimics containing
monomeric nucleosides in conformationally restricted 3′-
endo-type configurations. This has been clearly demon-
strated by the superior recognition of complementary nucleic
acids by parent LNA,3 and the conformational analyses
presented here for 2′-amino- and 2′-thio-LNA monomeric
nucleosides indicate that the corresponding 2′-amino- and
2′-thio-LNA oligonucleotides deserve further attention. In
our design of novel oligonucleotide analogues, we have been
rather conservative, focusing on pentofuranose analogues
containing phosphate esters at the natural 3′- and 5′-
positions. This strategy has been successful in the case of
LNA, and incorporation of the 2′-amino-LNA nucleoside 7
into oligonucleotides could represent a significant step
forward offering a potentially convenient conjugation site
in a preorganized nucleic acid mimic structurally resembling
RNA. The synthetic route devised in this report gives
convenient access to 2′-heteroatom substituted LNA pyri-
midine nucleosides and should in addition also be applicable
for synthesis of other bicyclic pyrimidine nucleoside ana-
logues.
The conformation of 2′-amino-LNA nucleoside 7 and 2′-
thio-LNA nucleoside 11 was evaluated from the coupling
constants of the 1H NMR spectra as described earlier for
other nucleosides.8 Importantly, the J 1′,2′ values for the
bicyclo[2.2.1] nucleosides 7 and 11 were 0 Hz,9 indicating
Ack n ow led gm en t. The Danish Natural Science Re-
search Council, The Danish International Development
Agency, and Exiqon A/S, Denmark, are thanked for finan-
cial support.
(7) (a) Beig, T.; Szeja, W. Synthesis 1985, 76. (b) Kutney, J . P.;
Abdurahman, N.; Gletsos, C.; Quesue, L. P.; Piers, E.; Vlattas, I. J . Am.
Chem. Soc. 1970, 92, 1727. (c) Bell, D. J .; Lorber, J . J . Chem. Soc. 1940,
453. (d) Angyal, S. J .; J ames, K. Carbohydr. Res. 1970, 12, 147. (e) Sakurai,
H.; Shirahata, A.; Sasaki, K.; Hosomi, A. Synthesis 1979, 740.
(8) (a) Altona, C.; Sundaralingam, M. J . Am. Chem. Soc. 1973, 95, 2333.
(b) Obika, S.; Morio, K., Nanbu, D.; Imanishi, T. Chem. Commun. 1997,
1643.
Su p p or tin g In for m a tion Ava ila ble: Supporting Information
Available: Experimental procedures, spectroscopic data for com-
pounds 4-11 and a copy of the 13C NMR spectrum of compound
11 (8 pages).
(9) 1H NMR data for 7: δH (DMSO-d6) 11.29 (br s, 1H, NH), 7.73 (d, 1H,
J ) 1.1 Hz, 6-H), 5.31 (s, 1H, 1′-H), 5.29 (d, 1H, J ) 3.7 Hz, 3′-OH), 5.13 (t,
1H, J ) 5.3 Hz, 5′-OH), 3.81 (br s, 1H, 3′-H), 3.69 (m, 2H, 5′-H), 3.23 (s, 1H,
2′-H), 2.88 (d, 1H, J ) 9.8 Hz, 1′′-Ha), 2.55 (d, 1H, J ) 9.8 Hz, 1′′-Hb), 1.77
(d, 3H, J ) 0.8 Hz, CH3). 1H NMR data for 11: δH (CD3OD) 8.19 (1H, d, J
) 8.1 Hz, 6-H), 5.77 (1H, s, 1′-H), 5.65 (1H, d, J ) 8.1 Hz, 5-H), 4.31 (1H,
d, J ) 2.1 Hz, 3′-H), 3.86 (2H, s, 5′-H), 3.53 (1H, d, J ) 2.2 Hz, 2′-H), 2.93
(1H, d, J ) 10.3 Hz, 1′′-Ha), 2.73 (1H, d, J ) 10.3 Hz, 1′′-Hb).
J O9806658
(10) For 6b: 9% NOE in H-6 (irradiation of H-3′). For 7: 11% NOE in
H-6 (irradiation of H-3′) and 6% NOE in H-3′ (irradiation of H-6).